Investor profile

Compound logo

Compound

VC

USGBDEFRNLOtherAI/MLDeep TechBio/PharmaHealthtechFintechOther

See how your deck fits this investor's thesis, stage, and ticket size.

Analyse your fit

Investment thesis

Compound is a thesis-driven, research-centric investment firm focused on early-stage ventures across deeply technical and science-driven areas — most notably AI/ML, Robotics, Biology, and Crypto. The firm's mission is to help founders solve previously unsolvable technical problems, communicate breakthroughs to the world, and scale commercialization, leveraging a team of investors, researchers, and operators with deep domain expertise. Compound's investment philosophy centers on backing 'n-of-1' opportunities: early movers to fundamental breakthroughs and 'Final Movers' who understand the limits of existing consensus approaches and take more sophisticated, contrarian technological bets. The firm deliberately deploys capital during periods of low industry consensus, seeking asymmetric risk in underappreciated categories, and publishes its research theses openly to connect with the founders it wants to back.

Notable quotes

Our core competency at Compound is not necessarily an ability to pick the best company in a crowded, overfunded area, but instead to notice 'n-of-1' approaches or company types that are underappreciated or could be special for a variety of reasons.

Michael Dempsey · Compound 2023 Annual Letter (compound.vc) · 2024-04-19

Venture is in many ways about survival, so time and progress also continues to validate our mission of building a world class venture firm and portfolio while continuing to improve our ability to manage the complexities of deploying capital amongst cycles of low industry consensus.

Michael Dempsey · Compound 2023 Annual Letter (compound.vc) · 2024-04-19

I think I wasn't vibes based... companies need to think about value capture properly and competitive dynamics, and it's not just about doing fast ARR and expecting it to stick around.

Michael Dempsey · The Peel with Turner Novak (thespl.it / YouTube) · 2025-08-14

Team

Michael Dempsey

Managing Partner

AI/MLDeep TechBio/PharmaOther

David Hirsch

General Partner

AI/MLDeep TechOther

0xSmac

Partner

Other

Shelby Newsad

Partner

Bio/PharmaHealthtech

Mackenzie Morehead

Researcher

Bio/PharmaDeep TechOther

John Palmer

Venture Partner - Crypto

Other

Recent investments

CompanyRoundSizeDate
RunwaySeed
WayveSeries A$200m2022-01-01
DeepgramSeed
The GraphSeed
ArbitrumSeed
Dapper LabsSeed
Orbital MaterialsSeries B2024-01-01
Prime IntellectSeed2024-01-01
Fort RoboticsSeries A
Culture BiosciencesSeed

Frequent co-investors

Fit check

Is Compound a match for your startup?

Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.

Analyse your fit